Filing Details

Accession Number:
0001209191-15-046667
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-26 16:19:13
Reporting Period:
2015-05-21
Filing Date:
2015-05-26
Accepted Time:
2015-05-26 16:19:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
924717 Surmodics Inc SRDX Surgical & Medical Instruments & Apparatus (3841) 411356149
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412895 K Bryan Phillips 9924 West 74Th Street
Eden Prairie MN 55344
Svp, Gen Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-21 7,748 $9.25 33,435 No 4 M Direct
Common Stock Acquisiton 2015-05-21 5,367 $12.40 38,802 No 4 M Direct
Common Stock Disposition 2015-05-21 7,984 $25.94 30,818 No 4 F Direct
Common Stock Disposition 2015-05-22 7,293 $25.25 23,525 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-05-21 7,748 $0.00 7,748 $9.25
Common Stock Employee Stock Option (right to buy) Disposition 2015-05-21 5,367 $0.00 5,367 $12.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-11-30 No 4 M Direct
5,367 2018-11-30 No 4 M Direct
Footnotes
  1. The reporting person makes a payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.
  2. Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2015.
  3. Reflects the weighted average price of 7,293 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 22, 2015 with sale prices ranging from $24.92 to $25.81 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Fully vested.
  5. The award vests in four equal installments of each of the first four anniversaries of the November 30, 2011 grant date.